1206 related articles for article (PubMed ID: 8957075)
1. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M
Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of melanoma metastasis.
Bar-Eli M
J Cell Physiol; 1997 Nov; 173(2):275-8. PubMed ID: 9365536
[TBL] [Abstract][Full Text] [Related]
3. Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.
Huang S; Jean D; Luca M; Tainsky MA; Bar-Eli M
EMBO J; 1998 Aug; 17(15):4358-69. PubMed ID: 9687504
[TBL] [Abstract][Full Text] [Related]
4. Regulation of interleukin-8 expression in human melanoma cells by the organ environment.
Gutman M; Singh RK; Xie K; Bucana CD; Fidler IJ
Cancer Res; 1995 Jun; 55(11):2470-5. PubMed ID: 7758001
[TBL] [Abstract][Full Text] [Related]
5. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
Xie S; Price JE; Luca M; Jean D; Ronai Z; Bar-Eli M
Oncogene; 1997 Oct; 15(17):2069-75. PubMed ID: 9366524
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
[TBL] [Abstract][Full Text] [Related]
7. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
8. Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury.
Wang CH; Verma S; Hsieh IC; Hung A; Cheng TT; Wang SY; Liu YC; Stanford WL; Weisel RD; Li RK; Cherng WJ
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):540-7. PubMed ID: 17204664
[TBL] [Abstract][Full Text] [Related]
9. KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells.
Zakut R; Perlis R; Eliyahu S; Yarden Y; Givol D; Lyman SD; Halaban R
Oncogene; 1993 Aug; 8(8):2221-9. PubMed ID: 7687762
[TBL] [Abstract][Full Text] [Related]
10. Effects of stem cell factor on the growth and radiation survival of tumor cells.
Shui C; Khan WB; Leigh BR; Turner AM; Wilder RB; Knox SJ
Cancer Res; 1995 Aug; 55(15):3431-7. PubMed ID: 7542170
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
Pötgens AJ; van Altena MC; Lubsen NH; Ruiter DJ; de Waal RM
Am J Pathol; 1996 Apr; 148(4):1203-17. PubMed ID: 8644861
[TBL] [Abstract][Full Text] [Related]
12. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.
Montone KT; van Belle P; Elenitsas R; Elder DE
Mod Pathol; 1997 Sep; 10(9):939-44. PubMed ID: 9310959
[TBL] [Abstract][Full Text] [Related]
13. Stem cell factor suppresses apoptosis in neuroblastoma cell lines.
Timeus F; Crescenzio N; Valle P; Pistamiglio P; Piglione M; Garelli E; Ricotti E; Rocchi P; Strippoli P; Cordero di Montezemolo L; Madon E; Ramenghi U; Basso G
Exp Hematol; 1997 Nov; 25(12):1253-60. PubMed ID: 9357969
[TBL] [Abstract][Full Text] [Related]
14. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
15. Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications.
Welker P; Schadendorf D; Artuc M; Grabbe J; Henz BM
Br J Cancer; 2000 Apr; 82(8):1453-8. PubMed ID: 10780526
[TBL] [Abstract][Full Text] [Related]
16. Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma.
Giehl KA; Nägele U; Volkenandt M; Berking C
J Cutan Pathol; 2007 Jan; 34(1):7-14. PubMed ID: 17214848
[TBL] [Abstract][Full Text] [Related]
17. Introduction of the c-kit gene leads to growth suppression of a breast cancer cell line, MCF-7.
Nishida K; Tsukamoto T; Uchida K; Takahashi T; Takahashi T; Ueda R
Anticancer Res; 1996; 16(6B):3397-402. PubMed ID: 9042197
[TBL] [Abstract][Full Text] [Related]
18. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M
Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate.
Hofmann UB; Kauczok-Vetter CS; Houben R; Becker JC
Clin Cancer Res; 2009 Jan; 15(1):324-9. PubMed ID: 19118061
[TBL] [Abstract][Full Text] [Related]
20. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
